Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PolyNovo.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Poly oh no! Polynovo shares resume slide as CEO goes
Experts
Hot Money Monday: Expert says defence stocks should be in every investor’s portfolio
News
Lunch Wrap: ASX plunges as momentum trade unwinds; Polynovo rocked by bullying allegations
Health & Biotech
“Accelerate Action” to boost women’s leadership in Aussie healthcare sector
Health & Biotech
Health Check: Half-price sale as brokers ring the bell on Neuren shares
Experts
Criterion: Rollercoaster price movements are now part of the profit-reporting landscape
Health & Biotech
Scott Power: ASX healthcare stocks fall in ‘worst reporting season for a long time’
Health & Biotech
Health Check: You’re rehired! The Trump administration’s FDA staffing ‘fiasco’ puts sector in choppy, unchartered waters
Health & Biotech
Health Check: More, please! When record results are not good enough for expectant investors
Health & Biotech
Scott Power: ASX health stocks up in mixed earnings season, Mayne surges on $672 million US buyout
Health & Biotech
Scott Power: Cardiac pacing device developer EBR hits Morgans price target amid ‘rotation back into healthcare’
Health & Biotech
Scott Power: Telix achieves sustained growth; Pro Medicus wins another contract
Experts
Experts break down all 11 ASX sectors and serve up some stock tips
Experts
Hot Money Monday: Bell Potter backs these tech and healthcare stocks for 2025
Health & Biotech
Scott Power: Which ASX healthcare stock has soared 30pc this week?
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
